Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jun 3, 2023. (Total: 217635Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Hypoalbuminemia and EGFR[original query]
Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.
Neoplasma 2016 63 (3): 471-6.
Fiala O, Pesek M, Finek J, Racek J, Minarik M, Benesova L, Bortlicek Z, Sorejs O, Kucera R, Topolcan
Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study.
Journal of thoracic disease 2017 Dec 9 (12): 5068-5074.
Shen Qian, Dong Xiaoqi, Tang Xiaoping, Zhou Jianyi
Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment.
Journal of clinical medicine 2020 Jun 9 (6): .
Nakao Akira, Hiranuma Osamu, Uchino Junji, Sakaguchi Chikara, Araya Tomoyuki, Hiraoka Noriya, Ishizuka Tamotsu, Takeda Takayuki, Kawasaki Masayuki, Goto Yasuhiro, Imai Hisao, Hattori Noboru, Nakatomi Keita, Uramoto Hidetaka, Uryu Kiyoaki, Fukuda Minoru, Uchida Yasuki, Yokoyama Toshihide, Akai Masaya, Mio Tadashi, Nagashima Seiji, Chihara Yusuke, Tamiya Nobuyo, Kaneko Yoshiko, Mouri Takako, Yamada Tadaaki, Yoshimura Kenichi, Fujita Masaki, Takayama Koic
Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers.
Journal of bone oncology 2021 Dec 31 100394.
Meng Chunliu, Wei Jia, Tian Jia, Ma Jintao, Liu Ningbo, Yuan Zhiyong, Zhao Lujun, Wang Pi
Safety, pharmacokinetics, and efficacy of BPI-15086 in patients with EGFR T790M-mutated advanced non-small-cell lung cancer: results from a phase I, single-arm, multicenter study.
ESMO open 2022 5 7 (3): 100473.
Xing P, Zheng X, Wang Y, Chu T, Wang S, Jiang J, Qian J, Han X, Ding L, Wang Y, Cui L, Li H, Li L, Chen X, Han B, Hu P, Shi
TOP